The NIH’s new imposed standard indirect cost rate threatens life-saving brain and behavior research that benefits millions of Americans. SfN, with other scientific organizations, urge reversal of this policy and implore Congress to protect critical research infrastructure.
Read the full statement: https://t.co/8PnPiHrhFY
Headed to #SfN ? Check out our poster from the Lab of @EllenUnterwald on Monday Morning (poster # C106). I will be sharing our results on the effect of cocaine and SARS-CoV-2 spike protein on BBB permeability in vivo.
(Spoiler, the results will surprise you!)
https://t.co/sKhcE6DFUr
Another new article!
Impact of HIV-1 Tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 Tat transgenic mice
@JunZhu75623945
https://t.co/jQpiQS8soO
New article out: Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV
@JunZhu75623945
Had a great time at the Chemistry and Pharmacology of Drug Abuse meeting in Boston. It's great to see how far molecular modeling and Drug Discovery has come. Can't wait to share more of our story at SfN in October. #CPDA
Hey yall… Super late, but always reppin’ #BlackInNeuro I’m Lillian, an Asst. Prof. at UAB in the Dept. of Psychiatry, where my lab studies biological sex/hormone-specific effects of drugs of abuse and medications on neural circuit mechanisms underlying reward learning
#BINW24